AlphaNavi Pharma Inc. Alternatives & Competitors

12 companies similar to AlphaNavi Pharma Inc. — AlphaNavi Pharma is developing a unique voltage-gated sodium channel inhibitor f...

ALGOMEDIX, INC.

United States

Biotechnology Health and Wellness +1

Synerkine Pharma

Creating Innovative Pain Solutions

6 Series A $12.10M

Leiden, The Netherlands

Biotechnology Health Care

Semnur Pharmaceuticals, Inc.

2 Venture round $6.00M

Mountain View, United Sta...

Biotechnology Pharmaceutical

Cavion

Empowering therapies for cancer and neurologic diseases through pioneering ion channel inh...

Series A $31.10M

Biotechnology Health Care +1

Rival Readout

Competing with AlphaNavi Pharma Inc.? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

Synlogic

Designed for Life

20 IPO $422.40M

Cambridge, United States

Biotechnology Health Care +1

Adastra Pharmaceuticals

Adastra is committed to transforming cancer care.

11-50 Venture round $85.00M

Princeton, United States

Biotechnology Health Care +1

AlgoTx

AlgoTx develops novel therapeutic solutions for complex pain

9 Series B $35.60M

Suresnes, France

Biotechnology Information Technology +1

RiboNova, Inc.

Focused on Mitochondrial Disease & other serious rare diseases. R007 is our P2 ready asset...

7 Venture round $25.00K

Wynnewood, United States

Biotechnology Pharmaceutical

Akelos Inc

Developing Opioid Alternatives for Treating Neuropathic Pain. Now Recruiting Accredited In...

5 Grant $2.05M

New York, United States

Biopharma Biotechnology +2

Initiator Pharma

Empowering Lives Through Meaningful Therapies

9 Secondary Market $20.00M

Denmark

Biotechnology Health Care +1

Endeavor BioMedicines

Boldly pursuing development of transformational medicines that may restore hope for patien...

52 Series C $295.50M

San Diego, United States

Biotechnology Health Care

Arven Pharmaceuticals

Hücreden Bitmiş Ürüne- Biyoteknoloji

Istanbul, Turkey

Biotechnology Pharmaceutical

About AlphaNavi Pharma Inc.

AlphaNavi Pharma Inc. is a biotechnology startup based in Japan, founded in 2019. The company is focused on developing a unique voltage-gated sodium channel inhibitor, ANP-230, for the treatment of neuropathic pain, particularly targeting Nav1.7, Nav1.8, and Nav1.9.

Business keywords

Pharmaceuticals, Neuropathic Pain, Analgesic Drug, Sodium Channel Inhibitor, Clinical Development, Pain Management, Rare Pain Diseases, Precision Medicine, Phase 1/2 Study, Out-licensing, Academic Collaboration, Investor Collaboration

Frequently Asked Questions

Companies similar to AlphaNavi Pharma Inc. include ALGOMEDIX, INC., Synerkine Pharma, Semnur Pharmaceuticals, Inc., Cavion, Synlogic. They work in Biotechnology and Pharmaceutical and share AlphaNavi Pharma Inc.'s focus on pharmaceuticals, precision medicine and neuropathic pain.

Bounce Watch lists 12 companies that share AlphaNavi Pharma Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around AlphaNavi Pharma Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

AlphaNavi Pharma Inc. Profile ALGOMEDIX, INC. Alternatives Synerkine Pharma Alternatives Semnur Pharmaceuticals, Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at AlphaNavi Pharma Inc. on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 26 Jan 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.